Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ETHZilla Corp | 20,500 | reported | 16 Dec 2021 | tx 3+287,500 |
| Monopar Therapeutics | 1,500 | reported | 26 Dec 2025 | tx 4+43,461 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 26 Dec 2025 | PURCHASE | Monopar Therapeutics | 1,500 | 69.95 USD | first after silence |
| 02 Dec 2025 | GRANT_AWARD | Monopar Therapeutics | 7,135 | 0.00 USD | deriv |
| 02 Dec 2025 | GRANT_AWARD | Monopar Therapeutics | 9,826 | 0.00 USD | deriv |
| 03 Mar 2025 | GRANT_AWARD | Monopar Therapeutics | 25,000 | 0.00 USD | deriv |
| 16 Dec 2021 | PURCHASE | ETHZilla Corp | 8,000 | 3.98 USD | |
| 08 Dec 2021 | GRANT_AWARD | ETHZilla Corp | 275,000 | 0.00 USD | deriv |
| 10 Dec 2021 | PURCHASE | ETHZilla Corp | 4,500 | 3.90 USD |
1 purchase reported after at least 12 months of silence — most recent on 26 Dec 2025.